According to Benzinga Pro, during Q2, Kingstone Companies (NASDAQ:KINS) earned $2.09 million, a 2616.84% increase from the preceding quarter. Kingstone Companies also posted a total of $35.44 million in sales, a 2.45% increase since Q1.
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
Kingstone Companies (NASDAQ:KINS) reported quarterly losses of $(0.05) per share. This is a 121.74 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales